What is TrialReach?
TrialReach operates as a sophisticated digital platform, leveraging advanced technology to streamline user engagement and service delivery. Positioned at the intersection of high-growth digital services and enterprise-grade infrastructure, the company focuses on optimizing user experiences through intuitive interfaces and reliable backend support. By prioritizing seamless interaction and accessibility, TrialReach has carved out a distinct niche, effectively addressing the demands of a modern, tech-savvy user base while maintaining the rigorous standards required for large-scale operational success.
How much funding has TrialReach raised?
TrialReach has raised a total of $16.7M across 2 funding rounds:
Series A
$3.2M
Series B
$13.5M
Series A (2013): $3.2M with participation from Octopus Ventures and Amadeus Capital Partners
Series B (2015): $13.5M led by Smedvig Capital, Amadeus Capital Partners, and Octopus Investments
Key Investors in TrialReach
Octopus Ventures
A prominent UK-based venture capital firm specializing in tax-efficient investments and high-growth potential ventures across various sectors.
Amadeus Capital Partners
A global technology venture capital firm that provides strategic backing to high-growth companies from seed to later stages, with a focus on deep tech and enterprise software.
Smedvig Capital
The London-based arm of the Smedvig Family Office, focusing on growth-stage private equity and venture capital investments across the UK and European markets.
What's next for TrialReach?
With the infusion of $13.5M, TrialReach is strategically positioned to accelerate its market expansion and deepen its technological moat. The company's roadmap likely involves scaling its core infrastructure to accommodate increased demand while exploring new avenues for product diversification. By leveraging the expertise of its seasoned investor base, TrialReach is well-equipped to navigate the complexities of enterprise-level growth, focusing on long-term value creation and sustainable competitive advantage in an increasingly crowded digital marketplace.
See full TrialReach company page
